In Heart failure Heart failure means your heart is weak and cannot pump enough blood to your lungs and the rest of your body. The most common symptoms are breathlessness, tiredness, and swelling in your legs, ankles, abdomen and other parts of your body. Milrilact 10mg Injection makes it easier for your heart to pump blood around your body and is therefore an effective treatment for heart failure. This medicine will help relieve your symptoms, making you feel better and more energetic. You should make appropriate lifestyle changes (such as eating healthily and keeping active) to help this medicine be effective. Follow your doctor’s instructions carefully to get maximum benefit.
It is not known whether it is safe to consume alcohol with Milrilact 10mg Injection. Please consult your doctor.
Milrilact 10mg Injection may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Milrilact 10mg Injection is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
It is not known whether Milrilact 10mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Milrilact 10mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Milrilact 10mg Injection may be needed. Please consult your doctor.
Milrilact 10mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Milrilact 10mg Injection may not be needed in these patients. Please consult your doctor.
If you miss a dose of Milrilact 10mg Injection, skip it and continue with your normal schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: United Biotech Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Strathspey Labs Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sanofi India Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Molekule India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Samarth Life Sciences Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Neon Laboratories Ltd || ₹14.5/tablet (25% cheaper)